

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.20398985 |
| 2 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.90589494 |
| 3 | synaptic vesicle maturation (GO:0016188) | 3.89325761 |
| 4 | glutamate secretion (GO:0014047) | 3.78448224 |
| 5 | locomotory exploration behavior (GO:0035641) | 3.77977414 |
| 6 | synaptic vesicle exocytosis (GO:0016079) | 3.75169134 |
| 7 | vocalization behavior (GO:0071625) | 3.74765846 |
| 8 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.62563641 |
| 9 | proline transport (GO:0015824) | 3.45735256 |
| 10 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.44169876 |
| 11 | layer formation in cerebral cortex (GO:0021819) | 3.43619197 |
| 12 | neuronal action potential propagation (GO:0019227) | 3.41147844 |
| 13 | positive regulation of receptor recycling (GO:0001921) | 3.34890540 |
| 14 | activation of protein kinase A activity (GO:0034199) | 3.34299186 |
| 15 | neurotransmitter secretion (GO:0007269) | 3.28502811 |
| 16 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.28008824 |
| 17 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.24991008 |
| 18 | regulation of synaptic vesicle transport (GO:1902803) | 3.23703499 |
| 19 | neuron cell-cell adhesion (GO:0007158) | 3.11520060 |
| 20 | exploration behavior (GO:0035640) | 3.05240980 |
| 21 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.99342437 |
| 22 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.99341327 |
| 23 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.98614343 |
| 24 | dendritic spine morphogenesis (GO:0060997) | 2.97262862 |
| 25 | gamma-aminobutyric acid transport (GO:0015812) | 2.96625315 |
| 26 | protein localization to synapse (GO:0035418) | 2.96084859 |
| 27 | cellular potassium ion homeostasis (GO:0030007) | 2.93914271 |
| 28 | regulation of synapse structural plasticity (GO:0051823) | 2.92649618 |
| 29 | neuron recognition (GO:0008038) | 2.91650713 |
| 30 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.88861568 |
| 31 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.86230149 |
| 32 | cellular response to epinephrine stimulus (GO:0071872) | 2.85465767 |
| 33 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.84179874 |
| 34 | cellular response to catecholamine stimulus (GO:0071870) | 2.83992895 |
| 35 | cellular response to monoamine stimulus (GO:0071868) | 2.83992895 |
| 36 | mating behavior (GO:0007617) | 2.81897638 |
| 37 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.77541307 |
| 38 | neurotransmitter transport (GO:0006836) | 2.77358069 |
| 39 | regulation of platelet aggregation (GO:0090330) | 2.76411603 |
| 40 | glutamate receptor signaling pathway (GO:0007215) | 2.74109785 |
| 41 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 2.74090589 |
| 42 | positive regulation of neurotransmitter transport (GO:0051590) | 2.66532886 |
| 43 | axonal fasciculation (GO:0007413) | 2.65830789 |
| 44 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.64027950 |
| 45 | positive regulation of fibroblast migration (GO:0010763) | 2.61507651 |
| 46 | clathrin coat assembly (GO:0048268) | 2.60532065 |
| 47 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.59688063 |
| 48 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.56752384 |
| 49 | regulation of neurotransmitter levels (GO:0001505) | 2.56294725 |
| 50 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.55641503 |
| 51 | dendrite morphogenesis (GO:0048813) | 2.55338061 |
| 52 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.54871816 |
| 53 | neuron-neuron synaptic transmission (GO:0007270) | 2.54315663 |
| 54 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.53437061 |
| 55 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.52567341 |
| 56 | regulation of vesicle fusion (GO:0031338) | 2.52072165 |
| 57 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.51836194 |
| 58 | sodium ion export (GO:0071436) | 2.51626884 |
| 59 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.51242002 |
| 60 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.51195154 |
| 61 | positive regulation of vesicle fusion (GO:0031340) | 2.50306958 |
| 62 | regulation of receptor recycling (GO:0001919) | 2.50247961 |
| 63 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.49885688 |
| 64 | detection of calcium ion (GO:0005513) | 2.49533614 |
| 65 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.46360629 |
| 66 | vesicle transport along microtubule (GO:0047496) | 2.45449453 |
| 67 | synaptic transmission, glutamatergic (GO:0035249) | 2.45049697 |
| 68 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.44177188 |
| 69 | response to monoamine (GO:0071867) | 2.42623384 |
| 70 | response to catecholamine (GO:0071869) | 2.42623384 |
| 71 | negative regulation of inclusion body assembly (GO:0090084) | 2.42606994 |
| 72 | long-term memory (GO:0007616) | 2.42164582 |
| 73 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.40818432 |
| 74 | negative regulation of neurotransmitter transport (GO:0051589) | 2.39781802 |
| 75 | protein localization to endosome (GO:0036010) | 2.37828653 |
| 76 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.36848380 |
| 77 | nerve growth factor signaling pathway (GO:0038180) | 2.36805828 |
| 78 | negative regulation of microtubule polymerization (GO:0031115) | 2.36771838 |
| 79 | social behavior (GO:0035176) | 2.36629224 |
| 80 | intraspecies interaction between organisms (GO:0051703) | 2.36629224 |
| 81 | neuronal ion channel clustering (GO:0045161) | 2.35852136 |
| 82 | transmission of nerve impulse (GO:0019226) | 2.35435489 |
| 83 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.35256540 |
| 84 | L-amino acid import (GO:0043092) | 2.34786111 |
| 85 | regulation of postsynaptic membrane potential (GO:0060078) | 2.34411087 |
| 86 | regulation of synaptic plasticity (GO:0048167) | 2.33456821 |
| 87 | neuromuscular process controlling posture (GO:0050884) | 2.33263171 |
| 88 | glycine transport (GO:0015816) | 2.32901465 |
| 89 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.32863248 |
| 90 | cell communication by electrical coupling (GO:0010644) | 2.32654451 |
| 91 | neuromuscular process controlling balance (GO:0050885) | 2.32593164 |
| 92 | response to epinephrine (GO:0071871) | 2.32427108 |
| 93 | behavioral response to cocaine (GO:0048148) | 2.32111156 |
| 94 | regulation of early endosome to late endosome transport (GO:2000641) | 2.31938613 |
| 95 | alanine transport (GO:0032328) | 2.30704952 |
| 96 | neurotransmitter uptake (GO:0001504) | 2.27083711 |
| 97 | organelle transport along microtubule (GO:0072384) | 2.26910804 |
| 98 | negative regulation of protein localization to cell surface (GO:2000009) | 2.26505664 |
| 99 | prepulse inhibition (GO:0060134) | 2.26418190 |
| 100 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.26097959 |
| 101 | positive regulation of membrane potential (GO:0045838) | 2.25700617 |
| 102 | regulation of neurotransmitter secretion (GO:0046928) | 2.25454968 |
| 103 | regulation of female receptivity (GO:0045924) | 2.25414008 |
| 104 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 2.25105209 |
| 105 | cerebellar Purkinje cell layer development (GO:0021680) | 2.24139603 |
| 106 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.24038182 |
| 107 | long-term synaptic potentiation (GO:0060291) | 2.24027015 |
| 108 | synapse organization (GO:0050808) | 2.23107742 |
| 109 | negative regulation of heart contraction (GO:0045822) | 2.21146462 |
| 110 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.21114587 |
| 111 | regulation of dendritic spine development (GO:0060998) | 2.21093372 |
| 112 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.20807351 |
| 113 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.19749655 |
| 114 | suckling behavior (GO:0001967) | 2.19485265 |
| 115 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.19208548 |
| 116 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.19015604 |
| 117 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.18853353 |
| 118 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.18688780 |
| 119 | negative regulation of amino acid transport (GO:0051956) | 2.18136205 |
| 120 | synapse assembly (GO:0007416) | 2.18059572 |
| 121 | extracellular fibril organization (GO:0043206) | 2.17188153 |
| 122 | amino acid import (GO:0043090) | 2.16983673 |
| 123 | adenosine receptor signaling pathway (GO:0001973) | 2.16909407 |
| 124 | cell communication involved in cardiac conduction (GO:0086065) | 2.16888031 |
| 125 | regulation of ARF protein signal transduction (GO:0032012) | 2.15224282 |
| 126 | potassium ion import (GO:0010107) | 2.15167652 |
| 127 | female mating behavior (GO:0060180) | 2.14578917 |
| 128 | macroautophagy (GO:0016236) | 2.14394928 |
| 129 | multi-organism reproductive behavior (GO:0044705) | 2.13337651 |
| 130 | cerebellar granule cell differentiation (GO:0021707) | 2.13070936 |
| 131 | regulation of beta-amyloid formation (GO:1902003) | 2.13020648 |
| 132 | positive regulation of potassium ion transport (GO:0043268) | 2.12833157 |
| 133 | positive regulation of synapse maturation (GO:0090129) | 2.12132444 |
| 134 | regulation of glutamate secretion (GO:0014048) | 2.11995518 |
| 135 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.11882631 |
| 136 | cortical actin cytoskeleton organization (GO:0030866) | 2.11784810 |
| 137 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.11084824 |
| 138 | membrane depolarization during action potential (GO:0086010) | 2.10843849 |
| 139 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.10839720 |
| 140 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.10780504 |
| 141 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.10780504 |
| 142 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.10529095 |
| 143 | long term synaptic depression (GO:0060292) | 2.10175634 |
| 144 | membrane depolarization (GO:0051899) | 2.10081282 |
| 145 | regulation of neurotransmitter transport (GO:0051588) | 2.08824021 |
| 146 | synaptic vesicle endocytosis (GO:0048488) | 2.08745571 |
| 147 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.08660590 |
| 148 | potassium ion homeostasis (GO:0055075) | 2.08464380 |
| 149 | presynaptic membrane assembly (GO:0097105) | 2.08323820 |
| 150 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.08072618 |
| 151 | innervation (GO:0060384) | 2.07827060 |
| 152 | protein targeting to plasma membrane (GO:0072661) | 2.07739218 |
| 153 | cellular response to glucagon stimulus (GO:0071377) | 2.07664044 |
| 154 | vesicle docking involved in exocytosis (GO:0006904) | 2.07478481 |
| 155 | platelet aggregation (GO:0070527) | 2.06853731 |
| 156 | cell differentiation in hindbrain (GO:0021533) | 2.06465844 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.97689228 |
| 2 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.64493750 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.61657524 |
| 4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.60881914 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.42112662 |
| 6 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.34559760 |
| 7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.34559760 |
| 8 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.24357862 |
| 9 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.24000416 |
| 10 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.22683910 |
| 11 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.19732195 |
| 12 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.14015693 |
| 13 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.12566257 |
| 14 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.95941573 |
| 15 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.93328169 |
| 16 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.88719618 |
| 17 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.81345220 |
| 18 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.80456729 |
| 19 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.75282942 |
| 20 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.75098746 |
| 21 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.74910573 |
| 22 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.73684466 |
| 23 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.72071723 |
| 24 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.71318046 |
| 25 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.70347315 |
| 26 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.66719666 |
| 27 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.64868150 |
| 28 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.58288513 |
| 29 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.57863181 |
| 30 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.55515211 |
| 31 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.54103115 |
| 32 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.50345807 |
| 33 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.48647820 |
| 34 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.47637520 |
| 35 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.47578129 |
| 36 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.47577481 |
| 37 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.46366033 |
| 38 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.44875810 |
| 39 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.40545179 |
| 40 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.40206082 |
| 41 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.38459770 |
| 42 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.37266336 |
| 43 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.35437978 |
| 44 | GATA1_19941826_ChIP-Seq_K562_Human | 1.34568893 |
| 45 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.33844319 |
| 46 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.31287208 |
| 47 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.30288861 |
| 48 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.29804435 |
| 49 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.28271626 |
| 50 | P300_19829295_ChIP-Seq_ESCs_Human | 1.27288812 |
| 51 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.26570389 |
| 52 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.25066528 |
| 53 | AR_25329375_ChIP-Seq_VCAP_Human | 1.23725534 |
| 54 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.23676878 |
| 55 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.23525509 |
| 56 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.22825924 |
| 57 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.22346771 |
| 58 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.21231542 |
| 59 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.21094779 |
| 60 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.20972445 |
| 61 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.20669047 |
| 62 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.20017050 |
| 63 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.19470497 |
| 64 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.19470497 |
| 65 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.16731873 |
| 66 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.15896948 |
| 67 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.13683705 |
| 68 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.13109624 |
| 69 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.12940466 |
| 70 | GATA2_19941826_ChIP-Seq_K562_Human | 1.12783347 |
| 71 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.12200747 |
| 72 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.11454344 |
| 73 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.09837031 |
| 74 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.09631935 |
| 75 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.09500538 |
| 76 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.09231001 |
| 77 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.09189380 |
| 78 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08982392 |
| 79 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.08698495 |
| 80 | STAT3_23295773_ChIP-Seq_U87_Human | 1.08555719 |
| 81 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.08300983 |
| 82 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.08200304 |
| 83 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.07974416 |
| 84 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.07483972 |
| 85 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.07054709 |
| 86 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.06828720 |
| 87 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.06323386 |
| 88 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.06293486 |
| 89 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.05171023 |
| 90 | RXR_22108803_ChIP-Seq_LS180_Human | 1.04935406 |
| 91 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.03325250 |
| 92 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.03199323 |
| 93 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.02803567 |
| 94 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.02156750 |
| 95 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.01993300 |
| 96 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.01429533 |
| 97 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.00842450 |
| 98 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.00127743 |
| 99 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99898108 |
| 100 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.99199933 |
| 101 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.98979411 |
| 102 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.98934047 |
| 103 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.98691537 |
| 104 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.98524675 |
| 105 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.98000757 |
| 106 | AR_19668381_ChIP-Seq_PC3_Human | 0.97788974 |
| 107 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.96776900 |
| 108 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.96457125 |
| 109 | TP53_16413492_ChIP-PET_HCT116_Human | 0.96412831 |
| 110 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.96354532 |
| 111 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.95361343 |
| 112 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.94728813 |
| 113 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.94064415 |
| 114 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.93366426 |
| 115 | CJUN_26792858_Chip-Seq_BT549_Human | 0.92245912 |
| 116 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.91913449 |
| 117 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.91804789 |
| 118 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.91455414 |
| 119 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.90676621 |
| 120 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.89676214 |
| 121 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.89638994 |
| 122 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.89486591 |
| 123 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.89030836 |
| 124 | * KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.89021366 |
| 125 | KDM2B_26808549_Chip-Seq_K562_Human | 0.88142059 |
| 126 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.87429103 |
| 127 | VDR_22108803_ChIP-Seq_LS180_Human | 0.86938574 |
| 128 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.85077949 |
| 129 | TCF4_23295773_ChIP-Seq_U87_Human | 0.84752423 |
| 130 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.84655416 |
| 131 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.83435412 |
| 132 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.82995538 |
| 133 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.82457099 |
| 134 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.78814795 |
| 135 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.78526763 |
| 136 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.78059810 |
| 137 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.77841474 |
| 138 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.77194477 |
| 139 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.77027413 |
| 140 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.76935720 |
| 141 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.76931604 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 4.56882275 |
| 2 | MP0003880_abnormal_central_pattern | 3.52992665 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.17428993 |
| 4 | MP0004270_analgesia | 3.00678685 |
| 5 | MP0005464_abnormal_platelet_physiology | 2.78416453 |
| 6 | MP0002837_dystrophic_cardiac_calcinosis | 2.60253359 |
| 7 | MP0009745_abnormal_behavioral_response | 2.51226444 |
| 8 | MP0009780_abnormal_chondrocyte_physiolo | 2.49711702 |
| 9 | MP0002063_abnormal_learning/memory/cond | 2.47958900 |
| 10 | MP0002064_seizures | 2.41146820 |
| 11 | MP0000569_abnormal_digit_pigmentation | 2.38452893 |
| 12 | MP0004510_myositis | 2.36252570 |
| 13 | MP0009046_muscle_twitch | 2.35612696 |
| 14 | MP0001501_abnormal_sleep_pattern | 2.27234321 |
| 15 | MP0000013_abnormal_adipose_tissue | 2.22909041 |
| 16 | MP0003329_amyloid_beta_deposits | 2.16153331 |
| 17 | MP0001440_abnormal_grooming_behavior | 2.11130016 |
| 18 | MP0002909_abnormal_adrenal_gland | 2.09156824 |
| 19 | MP0002734_abnormal_mechanical_nocicepti | 2.05149170 |
| 20 | MP0008260_abnormal_autophagy | 2.02241899 |
| 21 | MP0008004_abnormal_stomach_pH | 2.01863678 |
| 22 | MP0001968_abnormal_touch/_nociception | 2.01814658 |
| 23 | MP0002572_abnormal_emotion/affect_behav | 1.99380307 |
| 24 | MP0005409_darkened_coat_color | 1.99044304 |
| 25 | MP0002272_abnormal_nervous_system | 1.91698589 |
| 26 | MP0003705_abnormal_hypodermis_morpholog | 1.90726154 |
| 27 | MP0001486_abnormal_startle_reflex | 1.87069072 |
| 28 | MP0003656_abnormal_erythrocyte_physiolo | 1.82758092 |
| 29 | MP0003566_abnormal_cell_adhesion | 1.82447371 |
| 30 | MP0004130_abnormal_muscle_cell | 1.80462879 |
| 31 | MP0002139_abnormal_hepatobiliary_system | 1.77690811 |
| 32 | MP0006276_abnormal_autonomic_nervous | 1.77231560 |
| 33 | MP0005423_abnormal_somatic_nervous | 1.76885812 |
| 34 | MP0003828_pulmonary_edema | 1.74925159 |
| 35 | MP0003091_abnormal_cell_migration | 1.72768088 |
| 36 | MP0001958_emphysema | 1.67929826 |
| 37 | MP0002733_abnormal_thermal_nociception | 1.65308734 |
| 38 | MP0002332_abnormal_exercise_endurance | 1.64671850 |
| 39 | MP0008438_abnormal_cutaneous_collagen | 1.62426111 |
| 40 | MP0003303_peritoneal_inflammation | 1.58612492 |
| 41 | MP0005535_abnormal_body_temperature | 1.58020717 |
| 42 | MP0010234_abnormal_vibrissa_follicle | 1.57279240 |
| 43 | MP0004084_abnormal_cardiac_muscle | 1.57061363 |
| 44 | MP0000751_myopathy | 1.56493574 |
| 45 | MP0002067_abnormal_sensory_capabilities | 1.47094881 |
| 46 | MP0001970_abnormal_pain_threshold | 1.47070210 |
| 47 | MP0003195_calcinosis | 1.45848013 |
| 48 | MP0002736_abnormal_nociception_after | 1.44346825 |
| 49 | MP0004145_abnormal_muscle_electrophysio | 1.44166241 |
| 50 | MP0005386_behavior/neurological_phenoty | 1.43713448 |
| 51 | MP0004924_abnormal_behavior | 1.43713448 |
| 52 | MP0002822_catalepsy | 1.43705769 |
| 53 | MP0004858_abnormal_nervous_system | 1.33647091 |
| 54 | MP0002184_abnormal_innervation | 1.31294125 |
| 55 | MP0003879_abnormal_hair_cell | 1.30495501 |
| 56 | MP0002735_abnormal_chemical_nociception | 1.29112960 |
| 57 | MP0003300_gastrointestinal_ulcer | 1.28675466 |
| 58 | MP0005360_urolithiasis | 1.27593683 |
| 59 | MP0005275_abnormal_skin_tensile | 1.26116994 |
| 60 | MP0000778_abnormal_nervous_system | 1.23453127 |
| 61 | MP0005085_abnormal_gallbladder_physiolo | 1.22542572 |
| 62 | MP0003724_increased_susceptibility_to | 1.21504184 |
| 63 | MP0004043_abnormal_pH_regulation | 1.20996330 |
| 64 | MP0000747_muscle_weakness | 1.20303025 |
| 65 | MP0000749_muscle_degeneration | 1.19767376 |
| 66 | MP0003633_abnormal_nervous_system | 1.18365216 |
| 67 | MP0003787_abnormal_imprinting | 1.18292870 |
| 68 | MP0008569_lethality_at_weaning | 1.18057335 |
| 69 | MP0000604_amyloidosis | 1.17393143 |
| 70 | MP0002557_abnormal_social/conspecific_i | 1.16767412 |
| 71 | MP0001984_abnormal_olfaction | 1.16651207 |
| 72 | MP0003690_abnormal_glial_cell | 1.15873475 |
| 73 | MP0004885_abnormal_endolymph | 1.14672757 |
| 74 | MP0002066_abnormal_motor_capabilities/c | 1.13941632 |
| 75 | MP0002972_abnormal_cardiac_muscle | 1.12562831 |
| 76 | MP0002876_abnormal_thyroid_physiology | 1.11252306 |
| 77 | MP0004811_abnormal_neuron_physiology | 1.10618812 |
| 78 | MP0004215_abnormal_myocardial_fiber | 1.09200148 |
| 79 | MP0003279_aneurysm | 1.09142706 |
| 80 | MP0010329_abnormal_lipoprotein_level | 1.08913636 |
| 81 | MP0000955_abnormal_spinal_cord | 1.06587480 |
| 82 | MP0008875_abnormal_xenobiotic_pharmacok | 1.06331779 |
| 83 | MP0005365_abnormal_bile_salt | 1.04208320 |
| 84 | MP0005187_abnormal_penis_morphology | 1.03131007 |
| 85 | MP0000003_abnormal_adipose_tissue | 1.02517709 |
| 86 | MP0004185_abnormal_adipocyte_glucose | 1.01473675 |
| 87 | MP0004484_altered_response_of | 1.00910675 |
| 88 | MP0004883_abnormal_blood_vessel | 1.00217424 |
| 89 | MP0001851_eye_inflammation | 0.99730792 |
| 90 | MP0005645_abnormal_hypothalamus_physiol | 0.99699442 |
| 91 | MP0002090_abnormal_vision | 0.97626189 |
| 92 | MP0001177_atelectasis | 0.97363082 |
| 93 | MP0001299_abnormal_eye_distance/ | 0.96339465 |
| 94 | MP0006138_congestive_heart_failure | 0.96131342 |
| 95 | MP0004036_abnormal_muscle_relaxation | 0.95999631 |
| 96 | MP0003172_abnormal_lysosome_physiology | 0.95998404 |
| 97 | MP0002882_abnormal_neuron_morphology | 0.93883691 |
| 98 | MP0001879_abnormal_lymphatic_vessel | 0.93475532 |
| 99 | MP0005620_abnormal_muscle_contractility | 0.93027174 |
| 100 | MP0002118_abnormal_lipid_homeostasis | 0.91428578 |
| 101 | MP0005388_respiratory_system_phenotype | 0.91193578 |
| 102 | MP0002133_abnormal_respiratory_system | 0.91193578 |
| 103 | MP0005666_abnormal_adipose_tissue | 0.90446131 |
| 104 | MP0003631_nervous_system_phenotype | 0.90354801 |
| 105 | MP0005375_adipose_tissue_phenotype | 0.89899843 |
| 106 | MP0010386_abnormal_urinary_bladder | 0.89792892 |
| 107 | MP0004087_abnormal_muscle_fiber | 0.87545236 |
| 108 | MP0002069_abnormal_eating/drinking_beha | 0.87502830 |
| 109 | MP0000759_abnormal_skeletal_muscle | 0.87470261 |
| 110 | MP0002877_abnormal_melanocyte_morpholog | 0.87454875 |
| 111 | MP0002971_abnormal_brown_adipose | 0.87023664 |
| 112 | MP0005646_abnormal_pituitary_gland | 0.86743064 |
| 113 | MP0003632_abnormal_nervous_system | 0.85957775 |
| 114 | MP0003646_muscle_fatigue | 0.85754549 |
| 115 | MP0004085_abnormal_heartbeat | 0.85516909 |
| 116 | MP0005332_abnormal_amino_acid | 0.85000774 |
| 117 | MP0000465_gastrointestinal_hemorrhage | 0.84805871 |
| 118 | MP0003183_abnormal_peptide_metabolism | 0.84790249 |
| 119 | MP0005623_abnormal_meninges_morphology | 0.84468685 |
| 120 | MP0003453_abnormal_keratinocyte_physiol | 0.84279859 |
| 121 | MP0008961_abnormal_basal_metabolism | 0.82737360 |
| 122 | MP0002078_abnormal_glucose_homeostasis | 0.82421399 |
| 123 | MP0003191_abnormal_cellular_cholesterol | 0.82421377 |
| 124 | MP0000343_altered_response_to | 0.81705825 |
| 125 | MP0008874_decreased_physiological_sensi | 0.81495534 |
| 126 | MP0001502_abnormal_circadian_rhythm | 0.81153370 |
| 127 | MP0001905_abnormal_dopamine_level | 0.80763649 |
| 128 | MP0005167_abnormal_blood-brain_barrier | 0.79770800 |
| 129 | MP0002295_abnormal_pulmonary_circulatio | 0.79112767 |
| 130 | MP0003283_abnormal_digestive_organ | 0.78398505 |
| 131 | MP0001188_hyperpigmentation | 0.77110417 |
| 132 | MP0003075_altered_response_to | 0.76982666 |
| 133 | MP0004142_abnormal_muscle_tone | 0.76845073 |
| 134 | MP0003634_abnormal_glial_cell | 0.76114898 |
| 135 | MP0001529_abnormal_vocalization | 0.75920197 |
| 136 | MP0004272_abnormal_basement_membrane | 0.74125677 |
| 137 | MP0005448_abnormal_energy_balance | 0.73046961 |
| 138 | MP0000920_abnormal_myelination | 0.72002300 |
| 139 | MP0001765_abnormal_ion_homeostasis | 0.71924511 |
| 140 | MP0002229_neurodegeneration | 0.71768847 |
| 141 | MP0004742_abnormal_vestibular_system | 0.70921834 |
| 142 | MP0000230_abnormal_systemic_arterial | 0.70202277 |
| 143 | MP0003252_abnormal_bile_duct | 0.69919189 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 5.50219999 |
| 2 | Visual hallucinations (HP:0002367) | 4.43530848 |
| 3 | Focal seizures (HP:0007359) | 4.19681160 |
| 4 | Increased mean platelet volume (HP:0011877) | 4.11208704 |
| 5 | Myokymia (HP:0002411) | 3.90543319 |
| 6 | Abnormal platelet volume (HP:0011876) | 3.76547110 |
| 7 | Menorrhagia (HP:0000132) | 3.69361324 |
| 8 | Prolonged bleeding time (HP:0003010) | 3.57221653 |
| 9 | Atonic seizures (HP:0010819) | 3.53175983 |
| 10 | Absence seizures (HP:0002121) | 3.44248816 |
| 11 | Generalized tonic-clonic seizures (HP:0002069) | 3.28355386 |
| 12 | Cerebral inclusion bodies (HP:0100314) | 3.11359019 |
| 13 | Dialeptic seizures (HP:0011146) | 3.11194241 |
| 14 | Neurofibrillary tangles (HP:0002185) | 3.04877281 |
| 15 | Action tremor (HP:0002345) | 2.95461089 |
| 16 | Diplopia (HP:0000651) | 2.85238697 |
| 17 | Abnormality of binocular vision (HP:0011514) | 2.85238697 |
| 18 | Gingival bleeding (HP:0000225) | 2.81273237 |
| 19 | Supranuclear gaze palsy (HP:0000605) | 2.77511435 |
| 20 | Arterial tortuosity (HP:0005116) | 2.77077385 |
| 21 | Pheochromocytoma (HP:0002666) | 2.72455913 |
| 22 | Obstructive sleep apnea (HP:0002870) | 2.67322172 |
| 23 | Epileptic encephalopathy (HP:0200134) | 2.66505587 |
| 24 | Vascular tortuosity (HP:0004948) | 2.66009504 |
| 25 | Febrile seizures (HP:0002373) | 2.60457864 |
| 26 | Purpura (HP:0000979) | 2.58209271 |
| 27 | Progressive cerebellar ataxia (HP:0002073) | 2.57274011 |
| 28 | Anxiety (HP:0000739) | 2.56255695 |
| 29 | Insidious onset (HP:0003587) | 2.54591472 |
| 30 | Termporal pattern (HP:0011008) | 2.54591472 |
| 31 | Type 1 muscle fiber predominance (HP:0003803) | 2.49544399 |
| 32 | Hyperventilation (HP:0002883) | 2.48694792 |
| 33 | Papillary thyroid carcinoma (HP:0002895) | 2.48627973 |
| 34 | Epistaxis (HP:0000421) | 2.48494913 |
| 35 | Lower limb amyotrophy (HP:0007210) | 2.44759440 |
| 36 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.40271219 |
| 37 | Impaired social interactions (HP:0000735) | 2.39629127 |
| 38 | Abnormal social behavior (HP:0012433) | 2.39629127 |
| 39 | Poor eye contact (HP:0000817) | 2.35202225 |
| 40 | Dysdiadochokinesis (HP:0002075) | 2.33004990 |
| 41 | Depression (HP:0000716) | 2.32623336 |
| 42 | Oligomenorrhea (HP:0000876) | 2.32291553 |
| 43 | Abnormal eating behavior (HP:0100738) | 2.32119855 |
| 44 | Spontaneous hematomas (HP:0007420) | 2.32078551 |
| 45 | Exercise-induced myalgia (HP:0003738) | 2.30981474 |
| 46 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.29553777 |
| 47 | Neuroendocrine neoplasm (HP:0100634) | 2.29517800 |
| 48 | Nemaline bodies (HP:0003798) | 2.29502154 |
| 49 | Protrusio acetabuli (HP:0003179) | 2.25574989 |
| 50 | Mutism (HP:0002300) | 2.24172817 |
| 51 | Muscle fiber inclusion bodies (HP:0100299) | 2.23665580 |
| 52 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.22113708 |
| 53 | Mitral stenosis (HP:0001718) | 2.21011277 |
| 54 | Ankle clonus (HP:0011448) | 2.20819824 |
| 55 | Intention tremor (HP:0002080) | 2.20809306 |
| 56 | Distal lower limb amyotrophy (HP:0008944) | 2.20598291 |
| 57 | Aortic aneurysm (HP:0004942) | 2.20418723 |
| 58 | Status epilepticus (HP:0002133) | 2.19903548 |
| 59 | Amblyopia (HP:0000646) | 2.19785272 |
| 60 | Ketoacidosis (HP:0001993) | 2.19067352 |
| 61 | Subaortic stenosis (HP:0001682) | 2.18949300 |
| 62 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.18949300 |
| 63 | Broad-based gait (HP:0002136) | 2.18689846 |
| 64 | Torticollis (HP:0000473) | 2.17671268 |
| 65 | Dysmetria (HP:0001310) | 2.17638078 |
| 66 | Gout (HP:0001997) | 2.15685159 |
| 67 | Papilledema (HP:0001085) | 2.14970386 |
| 68 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.14013076 |
| 69 | Postural instability (HP:0002172) | 2.13657798 |
| 70 | Global brain atrophy (HP:0002283) | 2.12261105 |
| 71 | Agitation (HP:0000713) | 2.09275929 |
| 72 | Progressive inability to walk (HP:0002505) | 2.08492904 |
| 73 | Petechiae (HP:0000967) | 2.07982634 |
| 74 | Fetal akinesia sequence (HP:0001989) | 2.06363319 |
| 75 | Drooling (HP:0002307) | 2.05231252 |
| 76 | Excessive salivation (HP:0003781) | 2.05231252 |
| 77 | Distal lower limb muscle weakness (HP:0009053) | 2.02728296 |
| 78 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.01693067 |
| 79 | Hyperlipoproteinemia (HP:0010980) | 1.98334253 |
| 80 | Foot dorsiflexor weakness (HP:0009027) | 1.97492995 |
| 81 | Increased variability in muscle fiber diameter (HP:0003557) | 1.97199393 |
| 82 | Ventricular fibrillation (HP:0001663) | 1.96822498 |
| 83 | Overgrowth (HP:0001548) | 1.96439141 |
| 84 | Poikilocytosis (HP:0004447) | 1.95319439 |
| 85 | Hyperthyroidism (HP:0000836) | 1.95256396 |
| 86 | Slow saccadic eye movements (HP:0000514) | 1.93183034 |
| 87 | Focal dystonia (HP:0004373) | 1.92885623 |
| 88 | Abnormality of the Achilles tendon (HP:0005109) | 1.92469620 |
| 89 | Truncal ataxia (HP:0002078) | 1.90573274 |
| 90 | Urinary urgency (HP:0000012) | 1.90425751 |
| 91 | Epileptiform EEG discharges (HP:0011182) | 1.89940074 |
| 92 | Hypercortisolism (HP:0001578) | 1.89801395 |
| 93 | EEG with generalized epileptiform discharges (HP:0011198) | 1.89546214 |
| 94 | Cerebral hemorrhage (HP:0001342) | 1.87607468 |
| 95 | Resting tremor (HP:0002322) | 1.86945476 |
| 96 | Ketosis (HP:0001946) | 1.86652456 |
| 97 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.86353706 |
| 98 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.86353706 |
| 99 | Abnormality of the foot musculature (HP:0001436) | 1.85105886 |
| 100 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.84921809 |
| 101 | Achilles tendon contracture (HP:0001771) | 1.84770093 |
| 102 | Craniofacial dystonia (HP:0012179) | 1.84338877 |
| 103 | Abnormality of the corticospinal tract (HP:0002492) | 1.84042961 |
| 104 | Buphthalmos (HP:0000557) | 1.83820963 |
| 105 | Generalized myoclonic seizures (HP:0002123) | 1.83339323 |
| 106 | Skin nodule (HP:0200036) | 1.83252497 |
| 107 | Tetraparesis (HP:0002273) | 1.82619834 |
| 108 | Rapidly progressive (HP:0003678) | 1.82363108 |
| 109 | Megalencephaly (HP:0001355) | 1.80988505 |
| 110 | Hyporeflexia of lower limbs (HP:0002600) | 1.80364811 |
| 111 | Hypsarrhythmia (HP:0002521) | 1.80228040 |
| 112 | Hemiplegia (HP:0002301) | 1.80178744 |
| 113 | Conjunctival telangiectasia (HP:0000524) | 1.79283624 |
| 114 | Frequent falls (HP:0002359) | 1.79187394 |
| 115 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.78497990 |
| 116 | Bradykinesia (HP:0002067) | 1.77407180 |
| 117 | Difficulty running (HP:0009046) | 1.76640849 |
| 118 | Deep venous thrombosis (HP:0002625) | 1.76386554 |
| 119 | Xanthomatosis (HP:0000991) | 1.76175989 |
| 120 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.75981449 |
| 121 | Postural tremor (HP:0002174) | 1.74310484 |
| 122 | Sudden death (HP:0001699) | 1.74194744 |
| 123 | Decreased motor nerve conduction velocity (HP:0003431) | 1.74147917 |
| 124 | Lower limb muscle weakness (HP:0007340) | 1.74006316 |
| 125 | Aortic dissection (HP:0002647) | 1.73245252 |
| 126 | Limb dystonia (HP:0002451) | 1.73148326 |
| 127 | Cholecystitis (HP:0001082) | 1.73141270 |
| 128 | Abnormal gallbladder physiology (HP:0012438) | 1.73141270 |
| 129 | Neuronal loss in central nervous system (HP:0002529) | 1.72605492 |
| 130 | Bundle branch block (HP:0011710) | 1.71898221 |
| 131 | Polyphagia (HP:0002591) | 1.71678379 |
| 132 | Akinesia (HP:0002304) | 1.71218345 |
| 133 | Slow progression (HP:0003677) | 1.69438206 |
| 134 | Aplasia involving bones of the extremities (HP:0009825) | 1.68093707 |
| 135 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.68093707 |
| 136 | Aplasia of the phalanges of the hand (HP:0009802) | 1.68093707 |
| 137 | Abnormal atrioventricular conduction (HP:0005150) | 1.67900481 |
| 138 | Impaired platelet aggregation (HP:0003540) | 1.67635791 |
| 139 | Abnormal platelet function (HP:0011869) | 1.67635791 |
| 140 | Peritonitis (HP:0002586) | 1.67622433 |
| 141 | Testicular neoplasm (HP:0010788) | 1.67006861 |
| 142 | Dysmetric saccades (HP:0000641) | 1.66974859 |
| 143 | Heart block (HP:0012722) | 1.66643018 |
| 144 | Muscle fiber splitting (HP:0003555) | 1.65442473 |
| 145 | Rigidity (HP:0002063) | 1.65349089 |
| 146 | Vertebral arch anomaly (HP:0008438) | 1.64942364 |
| 147 | Gaze-evoked nystagmus (HP:0000640) | 1.64231130 |
| 148 | Atrioventricular block (HP:0001678) | 1.64161053 |
| 149 | Spastic gait (HP:0002064) | 1.63950894 |
| 150 | Scanning speech (HP:0002168) | 1.63775344 |
| 151 | Myotonia (HP:0002486) | 1.63616839 |
| 152 | Calf muscle hypertrophy (HP:0008981) | 1.63584408 |
| 153 | Bronchomalacia (HP:0002780) | 1.63531270 |
| 154 | Hyperglycinemia (HP:0002154) | 1.63341897 |
| 155 | Tetraplegia (HP:0002445) | 1.62885210 |
| 156 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.62194893 |
| 157 | Increased circulating renin level (HP:0000848) | 1.61489687 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 3.45004189 |
| 2 | MAP3K9 | 3.28557467 |
| 3 | EPHA4 | 2.96436270 |
| 4 | MAP3K4 | 2.61919886 |
| 5 | MARK1 | 2.44812928 |
| 6 | KSR2 | 2.32464904 |
| 7 | MAP2K4 | 2.29315575 |
| 8 | NTRK1 | 2.17134124 |
| 9 | MINK1 | 2.15302504 |
| 10 | DAPK2 | 2.10520033 |
| 11 | PAK6 | 1.96630757 |
| 12 | PRKD3 | 1.86311243 |
| 13 | MAP2K7 | 1.80211860 |
| 14 | RIPK4 | 1.72077331 |
| 15 | PRPF4B | 1.70143816 |
| 16 | MAP3K2 | 1.69930451 |
| 17 | MAP3K12 | 1.63931947 |
| 18 | ARAF | 1.55286944 |
| 19 | LATS2 | 1.52259200 |
| 20 | CAMKK1 | 1.49381067 |
| 21 | GRK5 | 1.47619274 |
| 22 | PAK3 | 1.43877439 |
| 23 | PHKG2 | 1.43810576 |
| 24 | PHKG1 | 1.43810576 |
| 25 | NTRK2 | 1.40214581 |
| 26 | PNCK | 1.39059317 |
| 27 | FRK | 1.37271656 |
| 28 | MAP2K3 | 1.33633930 |
| 29 | KSR1 | 1.32723189 |
| 30 | MYLK | 1.31930821 |
| 31 | CDK5 | 1.30154326 |
| 32 | TTN | 1.29983652 |
| 33 | TRIB3 | 1.28281481 |
| 34 | OXSR1 | 1.23240617 |
| 35 | PLK2 | 1.16782207 |
| 36 | WNK4 | 1.16444118 |
| 37 | RET | 1.15888306 |
| 38 | FER | 1.15353021 |
| 39 | FGFR2 | 1.14247877 |
| 40 | PINK1 | 1.13269772 |
| 41 | STK39 | 1.12541110 |
| 42 | CAMKK2 | 1.09198835 |
| 43 | STK38 | 1.06850445 |
| 44 | MARK2 | 1.06739349 |
| 45 | CAMK1G | 1.06706625 |
| 46 | MAP3K11 | 1.06296494 |
| 47 | TYRO3 | 1.05838583 |
| 48 | MAP3K3 | 1.01357295 |
| 49 | PRKCG | 1.01009372 |
| 50 | BMX | 1.00544646 |
| 51 | PTK2B | 0.99766952 |
| 52 | CAMK2A | 0.99725658 |
| 53 | MAP2K1 | 0.99178367 |
| 54 | STK11 | 0.97972235 |
| 55 | PDK4 | 0.97548571 |
| 56 | PDK3 | 0.97548571 |
| 57 | DDR2 | 0.92675960 |
| 58 | PRKCH | 0.91452597 |
| 59 | CSNK1G2 | 0.91367155 |
| 60 | MAP3K5 | 0.89791948 |
| 61 | MAP3K13 | 0.89613645 |
| 62 | STK24 | 0.89245896 |
| 63 | TAOK2 | 0.88703802 |
| 64 | GRK6 | 0.87877797 |
| 65 | WNK3 | 0.87383969 |
| 66 | SGK223 | 0.83869959 |
| 67 | SGK494 | 0.83869959 |
| 68 | MAP3K1 | 0.83062359 |
| 69 | PDGFRA | 0.81264767 |
| 70 | PDPK1 | 0.81176506 |
| 71 | CASK | 0.80994403 |
| 72 | OBSCN | 0.80859761 |
| 73 | DMPK | 0.80003719 |
| 74 | TAOK1 | 0.77775520 |
| 75 | INSRR | 0.74758815 |
| 76 | CAMK2B | 0.73735361 |
| 77 | ROCK2 | 0.73393210 |
| 78 | PRKCE | 0.72545429 |
| 79 | RIPK1 | 0.71967892 |
| 80 | CAMK2G | 0.71357818 |
| 81 | PDGFRB | 0.70885108 |
| 82 | MAPK13 | 0.68751885 |
| 83 | IRAK2 | 0.68741118 |
| 84 | SIK2 | 0.68515573 |
| 85 | YES1 | 0.67163270 |
| 86 | DYRK1B | 0.67070922 |
| 87 | CAMK2D | 0.65256628 |
| 88 | JAK1 | 0.64700139 |
| 89 | LMTK2 | 0.64590708 |
| 90 | SGK1 | 0.63063757 |
| 91 | WNK1 | 0.62234224 |
| 92 | UHMK1 | 0.62164532 |
| 93 | CDK14 | 0.61707568 |
| 94 | BMPR2 | 0.61321314 |
| 95 | PDK1 | 0.61109979 |
| 96 | ERBB2 | 0.60654261 |
| 97 | FES | 0.59158461 |
| 98 | PRKCZ | 0.58754945 |
| 99 | CAMK1 | 0.58420242 |
| 100 | PDK2 | 0.58133717 |
| 101 | DAPK1 | 0.56871255 |
| 102 | SGK3 | 0.55591916 |
| 103 | FGR | 0.54838995 |
| 104 | DYRK1A | 0.53429784 |
| 105 | NME1 | 0.53357928 |
| 106 | TESK1 | 0.53080195 |
| 107 | AKT3 | 0.52732678 |
| 108 | MAPK7 | 0.52111414 |
| 109 | EPHB1 | 0.51608749 |
| 110 | MOS | 0.51578945 |
| 111 | NEK9 | 0.51268837 |
| 112 | JAK2 | 0.50641498 |
| 113 | CDK15 | 0.50485460 |
| 114 | CAMK1D | 0.50469702 |
| 115 | PIK3CG | 0.50459703 |
| 116 | SGK2 | 0.50390691 |
| 117 | RAF1 | 0.49838898 |
| 118 | SCYL2 | 0.49692167 |
| 119 | FYN | 0.49277552 |
| 120 | ZAP70 | 0.48748749 |
| 121 | TRPM7 | 0.48657276 |
| 122 | CDK18 | 0.48248864 |
| 123 | FGFR3 | 0.47498328 |
| 124 | MAP3K7 | 0.46160811 |
| 125 | RPS6KA3 | 0.45669481 |
| 126 | PRKAA1 | 0.45514898 |
| 127 | PTK2 | 0.44679622 |
| 128 | ABL2 | 0.43451300 |
| 129 | MAPK12 | 0.43376356 |
| 130 | MST1R | 0.43181496 |
| 131 | MAP3K6 | 0.43087276 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.32468921 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 2.31772938 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.28633343 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 1.99794282 |
| 5 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.84307704 |
| 6 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.82943380 |
| 7 | Long-term potentiation_Homo sapiens_hsa04720 | 1.77866463 |
| 8 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.72565730 |
| 9 | Circadian entrainment_Homo sapiens_hsa04713 | 1.71034023 |
| 10 | Olfactory transduction_Homo sapiens_hsa04740 | 1.70425334 |
| 11 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.63418810 |
| 12 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.61941731 |
| 13 | Morphine addiction_Homo sapiens_hsa05032 | 1.60720104 |
| 14 | Salivary secretion_Homo sapiens_hsa04970 | 1.57238991 |
| 15 | Insulin secretion_Homo sapiens_hsa04911 | 1.56532686 |
| 16 | Platelet activation_Homo sapiens_hsa04611 | 1.55214695 |
| 17 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.50734016 |
| 18 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.49879116 |
| 19 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.46515258 |
| 20 | Renin secretion_Homo sapiens_hsa04924 | 1.45939568 |
| 21 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.37530824 |
| 22 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.36185957 |
| 23 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.35998592 |
| 24 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.27694623 |
| 25 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.27573698 |
| 26 | Taste transduction_Homo sapiens_hsa04742 | 1.27271392 |
| 27 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.26368427 |
| 28 | Cocaine addiction_Homo sapiens_hsa05030 | 1.24104030 |
| 29 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.22718059 |
| 30 | Long-term depression_Homo sapiens_hsa04730 | 1.19708304 |
| 31 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.16946295 |
| 32 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.15741146 |
| 33 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.12778305 |
| 34 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.11188542 |
| 35 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.10758123 |
| 36 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.09878285 |
| 37 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.08189427 |
| 38 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.07646700 |
| 39 | Endometrial cancer_Homo sapiens_hsa05213 | 1.07522231 |
| 40 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.06391966 |
| 41 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.06338241 |
| 42 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.05989217 |
| 43 | Focal adhesion_Homo sapiens_hsa04510 | 1.03219275 |
| 44 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.02753523 |
| 45 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.01767330 |
| 46 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.01227220 |
| 47 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.01091371 |
| 48 | Bile secretion_Homo sapiens_hsa04976 | 1.00815617 |
| 49 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.00471414 |
| 50 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.99554966 |
| 51 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.98764823 |
| 52 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.97977553 |
| 53 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.97634443 |
| 54 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.97470517 |
| 55 | Gap junction_Homo sapiens_hsa04540 | 0.94985346 |
| 56 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.94839643 |
| 57 | Endocytosis_Homo sapiens_hsa04144 | 0.93377311 |
| 58 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.93186603 |
| 59 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.91733265 |
| 60 | Amoebiasis_Homo sapiens_hsa05146 | 0.90706309 |
| 61 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.90631281 |
| 62 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.90585669 |
| 63 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.88939766 |
| 64 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.88422917 |
| 65 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.87786112 |
| 66 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.87066211 |
| 67 | Circadian rhythm_Homo sapiens_hsa04710 | 0.86156895 |
| 68 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.86137259 |
| 69 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.85794371 |
| 70 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.85714933 |
| 71 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.83000561 |
| 72 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.82363006 |
| 73 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.82297589 |
| 74 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.82273212 |
| 75 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.82148357 |
| 76 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.82100812 |
| 77 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.81525553 |
| 78 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.81354619 |
| 79 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.81046512 |
| 80 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.80735957 |
| 81 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.80406383 |
| 82 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.79994297 |
| 83 | Glioma_Homo sapiens_hsa05214 | 0.79647113 |
| 84 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.79571710 |
| 85 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.79184012 |
| 86 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.78354013 |
| 87 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.78174793 |
| 88 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.77962462 |
| 89 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.77561159 |
| 90 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.76997331 |
| 91 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.75928031 |
| 92 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.75336860 |
| 93 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.75295547 |
| 94 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.74746557 |
| 95 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.74459179 |
| 96 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.71166284 |
| 97 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.70673889 |
| 98 | Melanogenesis_Homo sapiens_hsa04916 | 0.69876096 |
| 99 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.69012214 |
| 100 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.68692128 |
| 101 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.68255778 |
| 102 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.67559630 |
| 103 | Alzheimers disease_Homo sapiens_hsa05010 | 0.66843105 |
| 104 | Adherens junction_Homo sapiens_hsa04520 | 0.66260831 |
| 105 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.64165488 |
| 106 | Axon guidance_Homo sapiens_hsa04360 | 0.63652628 |
| 107 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.63444881 |
| 108 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.63120600 |
| 109 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.62597749 |
| 110 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.61498699 |
| 111 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.59145728 |
| 112 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.58113667 |
| 113 | Tight junction_Homo sapiens_hsa04530 | 0.57676104 |
| 114 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.57588038 |
| 115 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.56991839 |
| 116 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.56668668 |
| 117 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.55924977 |
| 118 | Prion diseases_Homo sapiens_hsa05020 | 0.54553510 |
| 119 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.53977104 |
| 120 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.53320923 |
| 121 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.52888117 |
| 122 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.52107463 |
| 123 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.51516839 |
| 124 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.48863846 |
| 125 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.48415444 |
| 126 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.47916599 |
| 127 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.47153428 |
| 128 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.47007566 |
| 129 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.45431773 |
| 130 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.44608301 |
| 131 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.44347053 |
| 132 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.42851095 |
| 133 | Parkinsons disease_Homo sapiens_hsa05012 | 0.42847257 |
| 134 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.42574868 |
| 135 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.41263220 |
| 136 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.40636413 |
| 137 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.40135590 |
| 138 | Peroxisome_Homo sapiens_hsa04146 | 0.39701886 |
| 139 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.39161969 |

